Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Blueblood VenturesBOM:539637 PE Ratio (TTM) is 100.64 as of Aug. 05, 2026, which is 85% above its 10-year median of 54.38. The stock has 6 warning signs investors should review.
The PE Ratio (TTM), or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). As of today (2026-08-05), Blueblood Ventures's share price is
₹11.07.
Blueblood Ventures's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹0.11. Therefore, Blueblood Ventures's PE Ratio (TTM) for today is 100.64.
Good Sign:
Blueblood Ventures Ltd stock PE Ratio (=100.64) is close to 1-year low of 100.64.
The historical rank and industry rank for Blueblood Ventures's PE Ratio (TTM) or its related term are showing as below:
BOM:539637'
s PE Ratio (TTM) Range Over the Past 10 Years
Min: 12.48 Med: 54.38 Max: 553.5
Current: 100.64
During the past 12 years, the highest PE Ratio (TTM) of Blueblood Ventures was 553.50. The lowest was 12.48. And the median was 54.38.
BOM:539637's PE Ratio (TTM) is not ranked
in the Capital Markets industry.
Industry Median: 16.32
vs BOM:539637: 100.64
During the past 12 years, Blueblood Ventures's highest 3-Year average EPS without NRI Growth Rate was 72.00% per year. The lowest was -34.10% per year. And the median was 22.40% per year.
Blueblood Ventures's EPS (Basic) for the
six
months ended in Mar. 2026 was ₹-0.46.
Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹0.11.
Blueblood Ventures (BOM:539637) PE Ratio (TTM) Explanation
The PE Ratio (TTM) can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. For example, if a company earns $2 a share per year, and the stock is traded at $30, the PE Ratio (TTM) is 15. Therefore it takes 15 years for the company to earn back the $30 you paid for its stock, assuming the earnings stays constant over the next 15 years.
In real business, earnings never stay constant. If a company can grow its earnings, it takes fewer years for the company to earn back the price you pay for the stock. If a company's earnings decline it takes more years. As a shareholder, you want the company to earn back the price you pay as soon as possible. Therefore, lower P/E stocks are more attractive than higher P/E stocks so long as the PE Ratio (TTM) is positive. Also for stocks with the same PE Ratio (TTM), the one with faster growth business is more attractive.
If a company loses money, the PE Ratio (TTM) becomes meaningless.
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the PE Ratio (TTM) divided by the growth ratio. He thinks a company with a PE Ratio (TTM) equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a PE Ratio (TTM) of 20, instead of a company growing 10% a year with a PE Ratio (TTM) of 10.
Because the PE Ratio (TTM) measures how long it takes to earn back the price you pay, the PE Ratio (TTM) can be applied to the stocks across different industries. That is why it is the one of the most important and widely used indicators for the valuation of stocks.
Investors need to be aware that the PE Ratio (TTM) can be misleading a lot of times, especially when the underlying business is cyclical and unpredictable. As Peter Lynch pointed out, cyclical businesses have higher profit margins at the peaks of the business cycles. Their earnings are high and PE Ratio (TTM)s are artificially low. It is usually a bad idea to buy a cyclical business when the PE Ratio (TTM) is low. A better ratio to identify the time to buy a cyclical businesses is the PS Ratio .
PE Ratio (TTM) can also be affected by non-recurring-items such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio (TTM).
Blueblood Ventures PE Ratio (TTM) Related Terms
Blueblood Ventures PE Ratio (TTM) Historical Data
* Premium members only.
The historical data trend for Blueblood Ventures's PE Ratio (TTM) can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:539637 vs MS, SCHW, GS: PE Ratio (TTM) Comparison
For the Capital Markets subindustry, Blueblood Ventures's PE Ratio (TTM), along with its competitors' market caps and PE Ratio (TTM) data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Blueblood Ventures PE Ratio (TTM) vs Capital Markets Industry
For the Capital Markets industry and Financial Services sector, Blueblood Ventures's PE Ratio (TTM) distribution charts can be found below:
* The bar in red indicates where Blueblood Ventures's PE Ratio (TTM) falls into.
The PE Ratio (TTM), or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). It is the most widely used ratio in the valuation of stocks.
Blueblood Ventures's Share Price of today is ₹11.07.
For company reported semi-annually, Blueblood Ventures's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₹0.11.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
There are at least three kinds of PE Ratio (TTM)s used by different investors. They are Trailing Twelve Month PE Ratio (TTM) or PE Ratio (TTM) (TTM), Forward PE Ratio, or PE Ratio without NRI. A new PE Ratio (TTM) based on inflation-adjusted normalized PE Ratio (TTM) is called Shiller PE Ratio, after Yale professor Robert Shiller.
In the calculation of PE Ratio (TTM), the earnings per share used are the earnings per share over the past 12 months. For Forward PE Ratio, the earnings are the expected earnings for the next twelve months. In the case of PE Ratio without NRI, the reported earnings less the non-recurring items are used.
For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. Since it looks at the average over the last 10 years, Shiller PE Ratio is also called PE10.
Blueblood Ventures (BOM:539637) has a PE Ratio (TTM) of 100.64 as of Aug. 05, 2026. Trailing 12-month P/E ratio is the ratio of share price to a company's trailing 12-month earnings per share. View historical data on Blueblood Ventures and its competitors. This is 85% above median its historical median of 54.38. Over the past decade, Blueblood Ventures' PE Ratio (TTM) has ranged from 12.48 to 553.50.
Is Blueblood Ventures' PE Ratio (TTM) too high?
Blueblood Ventures' current PE Ratio (TTM) of 100.64 is 85% above median its 10-year median of 54.38. Over the past 10 years, this metric has ranged from a low of 12.48 to a high of 553.50. The Capital Markets industry median PE Ratio (TTM) is 16.32. Blueblood Ventures' value of 100.64 is 516.7% above this industry median.
How does Blueblood Ventures' PE Ratio (TTM) compare to MS and SCHW?
Blueblood Ventures' PE Ratio (TTM) of 100.64 can be compared against companies in the Capital Markets industry. The industry median PE Ratio (TTM) is 16.32. Blueblood Ventures' value of 100.64 is 516.7% above this benchmark. Historically, Blueblood Ventures' own PE Ratio (TTM) has ranged from 12.48 to 553.50 over the past decade. While the company's 10-year median is 54.38 vs. the industry median of 16.32, Blueblood Ventures has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PE Ratio (TTM) for a Capital Markets company?
The median PE Ratio (TTM) among Capital Markets companies is 16.32, based on 556 companies in the industry. Companies in the top quartile (top 25%) have a PE Ratio (TTM) significantly above this median, while those in the bottom quartile fall well below. However, PE Ratio (TTM) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Blueblood Ventures's current PE Ratio (TTM) of 100.64 is 516.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PE Ratio (TTM) mean?
A high PE Ratio (TTM) can signal that a stock is expensive relative to its fundamentals. Trailing 12-month P/E ratio is the ratio of share price to a company's trailing 12-month earnings per share. View historical data on Blueblood Ventures and its competitors. For the Capital Markets industry, the median PE Ratio (TTM) is 16.32 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Blueblood Ventures's current PE Ratio (TTM) is 100.64, which is 85% above median its own 10-year median of 54.38. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Blueblood Ventures stock overvalued right now?
Blueblood Ventures (BOM:539637) has a current PE Ratio (TTM) of 100.64. The stock's GF Value™ is ₹1.65, compared to a current price of ₹11.07 — trading 570.9% above its estimated fair value. The current PE Ratio (TTM) is 100.64, which is 85% above median its 10-year median of 54.38 and 516.7% above the Capital Markets industry median of 16.32. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PE Ratio (TTM) calculated?
PE Ratio (TTM) is calculated from a company's financial statements. For Blueblood Ventures (BOM:539637), the current PE Ratio (TTM) is 100.64 as of Aug. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Blueblood Ventures Ltd is engaged in the business of equity investment and trading in equity, derivatives, commodities, futures, and options, as well as other financial products. It also provides management and business consultancy. The company receives revenue from the sale of shares, securities, and commodities.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:539637 has been successfully added to your 
